Logo image of KERN

AKERNA CORP (KERN) Stock Fundamental Analysis

NASDAQ:KERN - Nasdaq - US00973W3007 - Common Stock - Currency: USD

0.3136  +0.08 (+36.94%)

After market: 0.364 +0.05 (+16.07%)

Fundamental Rating

0

Taking everything into account, KERN scores 0 out of 10 in our fundamental rating. KERN was compared to 282 industry peers in the Software industry. KERN may be in some trouble as it scores bad on both profitability and health. KERN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KERN had negative earnings in the past year.
In the past year KERN has reported a negative cash flow from operations.
KERN had negative earnings in each of the past 5 years.
KERN had a negative operating cash flow in each of the past 5 years.
KERN Yearly Net Income VS EBIT VS OCF VS FCFKERN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M

1.2 Ratios

KERN's Return On Assets of -821.29% is on the low side compared to the rest of the industry. KERN is outperformed by 98.92% of its industry peers.
Industry RankSector Rank
ROA -821.29%
ROE N/A
ROIC N/A
ROA(3y)-156.88%
ROA(5y)-120.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KERN Yearly ROA, ROE, ROICKERN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 500 1K 1.5K

1.3 Margins

The Gross Margin of KERN (56.92%) is worse than 61.37% of its industry peers.
In the last couple of years the Gross Margin of KERN has declined.
KERN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.77%
GM growth 5Y-4.94%
KERN Yearly Profit, Operating, Gross MarginsKERN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

KERN does not have a ROIC to compare to the WACC, probably because it is not profitable.
KERN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, KERN has a worse debt to assets ratio.
KERN Yearly Shares OutstandingKERN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M
KERN Yearly Total Debt VS Total AssetsKERN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

KERN has an Altman-Z score of -66.44. This is a bad value and indicates that KERN is not financially healthy and even has some risk of bankruptcy.
KERN has a Altman-Z score of -66.44. This is amonst the worse of the industry: KERN underperforms 97.11% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -66.44
ROIC/WACCN/A
WACC3.75%
KERN Yearly LT Debt VS Equity VS FCFKERN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 20M 40M

2.3 Liquidity

KERN has a Current Ratio of 0.10. This is a bad value and indicates that KERN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.10, KERN is doing worse than 98.56% of the companies in the same industry.
KERN has a Quick Ratio of 0.10. This is a bad value and indicates that KERN is not financially healthy enough and could expect problems in meeting its short term obligations.
KERN's Quick ratio of 0.10 is on the low side compared to the rest of the industry. KERN is outperformed by 98.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
KERN Yearly Current Assets VS Current LiabilitesKERN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.46% over the past year.
KERN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.66%.
The Revenue has been growing by 19.51% on average over the past years. This is quite good.
EPS 1Y (TTM)83.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.47%
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y8.05%
Revenue growth 5Y19.51%
Sales Q2Q%-32.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y95.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-57.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KERN Yearly Revenue VS EstimatesKERN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
KERN Yearly EPS VS EstimatesKERN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KERN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KERN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KERN Price Earnings VS Forward Price EarningsKERN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KERN Per share dataKERN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KERN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKERNA CORP

NASDAQ:KERN (2/8/2024, 8:00:03 PM)

After market: 0.364 +0.05 (+16.07%)

0.3136

+0.08 (+36.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2023-11-13/amc
Earnings (Next)03-19 2024-03-19/amc
Inst Owners0.7%
Inst Owner Change0%
Ins Owners40.64%
Ins Owner Change0%
Market Cap3.25M
Analysts43.33
Price Target0.82 (161.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.14%
Min EPS beat(2)-59.31%
Max EPS beat(2)27.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.32%
Min Revenue beat(2)-15.72%
Max Revenue beat(2)-14.93%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-37.79
EYN/A
EPS(NY)-1.55
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0.95
BVpS-0.89
TBVpS-1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -821.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.92%
FCFM N/A
ROA(3y)-156.88%
ROA(5y)-120.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.77%
GM growth 5Y-4.94%
F-Score3
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41.04%
Cap/Sales 10.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z -66.44
F-Score3
WACC3.75%
ROIC/WACCN/A
Cap/Depr(3y)132.74%
Cap/Depr(5y)N/A
Cap/Sales(3y)29.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.47%
EPS Next Y95.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y8.05%
Revenue growth 5Y19.51%
Sales Q2Q%-32.03%
Revenue Next Year-57.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.1%
OCF growth 3YN/A
OCF growth 5YN/A